Alex Santos: The Best Part Was Never on the Slides
Alex Santos, Consultant Sales Director, UK. Elixir Consulting LTD at Technoclone, shared a post on LinkedIn:
“Bye, Paris.
ISTH 2026 has drawn to a close, and what a week it’s been in the City of Light.
Between the buzz of the exhibition hall and conversations that spilled onto café terraces, one thing was clear: haemostasis is having a bright moment.
It was a real joy to share it all with the Technoclone team.
The talks on FXIa testing were a highlight for me, the thrombin generation sessions gave me plenty to think about, and everywhere you turned there was a growing conversation about bringing that insight closer to the patient through POCT.
But the best part was never on the slides.
It was the people beside them.
Old friends, new faces, and a shared curiosity about what flows next.
Thank you, Paris, for the light. ”
Other posts about ISTH Congress 2026 on Hemostasis Today.
-
Oct 28, 2026, 23:39Paul Tortland: What a New PRP Study Really Tells Us About Knee Osteoarthritis
-
Oct 28, 2026, 23:34Jawad Derbas: Comparing Mechanical and Pharmacomechanical VTE Prophylaxis in Spine Surgery
-
Oct 28, 2026, 23:31Giulio Maria Pasinetti: Aspirin Use Linked to Lower Dementia Risk in Older Adults With Specific Genetic Characteristics
-
Oct 28, 2026, 23:27Ralf Ludwig: Targeting Neutrophil-Driven Autoimmunity Through CDK Inhibition
-
Oct 28, 2026, 23:26Houda Moustaide: Great Discussions During Our Training Day on Thrombocytopenia in Pregnancy
-
Oct 28, 2026, 23:22Keith Berelowitz: Building Better Medicines by Listening to Patients With Bleeding Disorders
-
Oct 28, 2026, 23:19Nickie Enos: Blood Clots in Arteries and Veins Differ in Symptoms and Treatment
-
Oct 28, 2026, 23:17David Rosenblum: Can Concentrated PRP Actually Cause Scar Tissue?
-
Oct 28, 2026, 23:15Shueh Hao Lim: Advancing Multidisciplinary Care for Venous Thromboembolism in Malaysia